rationale for targeting fpr2 in female patients with pancreatic cancer
Published 2 years ago • 76 plays • Length 0:39Download video MP4
Download video MP3
Similar videos
-
2:02
targeted therapies for personalized medicine in pancreatic cancer
-
1:10
future targets for pancreatic cancer treatment
-
1:20
differences in tumor microenvironment between female and male patients with pancreatic cancer
-
2:33
precision medicine approaches in pancreatic cancer
-
1:43
identifying alternative molecular targets using ngs in pancreatic cancer
-
0:51
personalized treatment approaches for patients with kras-mutant pancreatic cancer
-
35:06
immune cells as targets for therapy in pancreatic cancer
-
1:23
destiny-pantumor02: trastuzumab deruxtecan in btc and pancreatic cancer
-
1:50
implementing precision oncology in pancreatic cancer
-
2:30
manipulating the microbiome of patients with pancreatic cancer to increase response to treatment
-
0:47
remaining areas of unmet need for patients with locally advanced pancreatic cancer
-
1:45
the future of precision oncology in pancreatic cancer
-
0:53
rationale for locally aggressive treatment of pancreatic cancer
-
3:34
canfour: targeting il1rap for nsclc or pancreatic cancer
-
1:50
genetic testing should be considered for all patients with pancreatic cancer
-
0:40
advances in molecular targeted therapies for pancreatic cancer
-
1:32
pancreatic cancer: the next 10 years
-
1:56
predicting os with pfs in pancreatic cancer in the napoleon-1 and -2 trials
-
1:28
nalirifox as frontline therapy for pdac